fbpx
Friday, April 26, 2024
HomeNewsZim Making Steady Progress Against COVID-19: ED

Zim Making Steady Progress Against COVID-19: ED

www.263chat.com

President Emmerson Mnangagwa says the country is making steady progress in the fight against the COVID-19 pandemic as a result of the on-going vaccination roll out programme.

Speaking at the Robert Gabriel Mugabe International airport where he received the second batch of 400 000 Sinopharm COVID-19 vaccines China, Mnangagwa said the national inoculation programme will guarantee the achievement of Vision 2030.

“We are making steady progress in the fight against the pandemic and in the on-going National COVID-19 Vaccination Roll-out Programme. My administration is confident that this vaccination intervention will greatly contribute to our country’s realisation of herd immunity.

“The National COVID-19 Vaccination Programme will further guarantee a Zimbabwe that continues on its course to achieve Vision 2030. We are determined to emerge out of this pandemic with greater capability to play a more effective role towards peace, harmony and prosperity within the comity of nations,” said Mnangagwa

The country is also expecting to receive 75 000 doses of the inactivated Covaxin from India and another donation of 20 000 doses of Sputnik-V vaccine from Russia.

The Zimbabwean government aims to vaccinate more than 9 million of its citizens and has recorded more than 36,321 coronavirus cases, including 1,489 deaths.

Last month, the Government embarked on a national COVID-19 vaccination program soon after receiving a donation of 200,000 doses of the Sinopharm vaccine from China. Zimbabwe also approved the use of India’s Covaxin vaccine last week.

ALSO ON 263Chat:  Police Chastised For Causing Death Of Tortured Woman

The vaccines arrived at the Robert Mugabe International Airport aboard an Air Zimbabwe plane with 400 000 thousand doses, 200 000 donated ones while 200 000 are part of those government has procured.

 

Share this article

No comments

Sorry, the comment form is closed at this time.

You cannot copy content of this page